X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MOLECULAR CARCINOGENESIS

期刊標題檢索 MOL CARCINOGEN 最新評論: Research focus: Tumor experience sharing: It has been over a month si... (2024-05-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MOLECULAR CARCINOGENESIS]您好,您是該頁面的第 69384 位訪客。

期刊簡介
期刊名稱MOLECULAR CARCINOGENESIS MOLECULAR CARCINOGENESIS
LetPub Score
7.5
50 ratings
Rate

Reputation
8.7

Influence
6.3

Speed
7.0

期刊簡稱MOL CARCINOGEN
ISSN0899-1987
E-ISSN1098-2744
h-index88
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.301.0340.748
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q281 / 230
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q2153 / 410

自引率 (2023-2024)3.30%自引率趨勢
掲載範囲
Molecular Carcinogenesis publishes articles describing discoveries in basic and clinical science of the mechanisms involved in chemical-, environmental-, physical (e.g., radiation, trauma)-, infection and inflammation-associated cancer development, basic mechanisms of cancer prevention and therapy, the function of oncogenes and tumors suppressors, and the role of biomarkers for cancer risk prediction, molecular diagnosis and prognosis.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744
在線稿件提交http://mc.manuscriptcentral.com/mc-wiley
開放訪問No
出版商Wiley-Liss Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1988
每年文章數151每年文章數趨勢
黃金OA百分比13.47%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ3171/313
ONCOLOGYSCIEQ2142/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0899-1987%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【MOLECULAR CARCINOGENESIS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1280291
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS571098
    JOURNAL OF BIOLOGICAL CHEMISTRY396001
    NUCLEIC ACIDS RESEARCH338185
    CELL298281
    FASEB JOURNAL267229
    International Journal of Biological Sciences236932
    PLANT SCIENCE228220
    Molecular Cancer213926
    ONCOGENE200964
  •  

    MOLECULAR CARCINOGENESIS MOLECULAR CARCINOGENESIS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)
  [MOLECULAR CARCINOGENESIS] 的評論撰寫評論
作者: Augus Fowler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-14 13:38:51 評論於
Research focus: Tumor experience sharing: It has been over a month since submission, and it has been under review since the second day without any changes. I am not sure if it has been sent for external review, feeling anxious but hesitant to urge
(0) 讚! | Augus Fowler

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-29 12:31:59 評論於
I'm about to collapse, I can't wait any longer
(0) 讚! | 岱宗雨旋

作者: 韦陀耀坤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 20:00:02 評論於
Still no news
(0) 讚! | 韦陀耀坤

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 22:59:36 評論於
How are you? Any updates? Mine is similar to yours, still waiting for the revisions and external review
(0) 讚! | 岱宗雨旋

作者: 蒙德高昂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 22:36:55 評論於
Do you need the original data for this magazine, experts?
(0) 讚! | 蒙德高昂

作者: Augus Fowler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 18:22:39 評論於
Hello, may I ask if this magazine under Review (with a capital R) is being edited or has been sent out for external review? It has been a week already
(0) 讚! | Augus Fowler

作者: Augus Fowler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 12:58:33 評論於
Hello, may I ask if this magazine under Review (capital R) is being edited or has been sent for external review? It has been one week already
(0) 讚! | Augus Fowler

作者: 平原从安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-06 09:49:36 評論於
Review speed: 6.0
Research focus: Tumor
Experience sharing: Submitted on December 23, 2023, revised on February 5, 2024, with four issues. Revised on March 18, 2024, and still no news until now
(0) 讚! | 平原从安

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-29 15:30:43 評論於
How was it finally resolved, may I ask?
(0) 讚! | 岱宗雨旋

作者: 韦陀耀坤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-24 11:08:21 評論於
Research focus: Tumors; Non-coding RNA; Molecular Mechanisms
Sharing of Experience: I have revised the manuscript three times, and after the third revision, it was sent out for external review for one month. The key point in the third review was just two descriptive issues, I don't know what they are nitpicking about
(0) 讚! | 韦陀耀坤

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-12 23:37:14 評論於
There is something about you that makes my heart race
(0) 讚! | 墟散云泽

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 17:18:33 評論於
Major revision was given 60 days. Two reviewers did not require additional experiments, mostly clarifications on wording and some supplementary data methods, which have all been addressed. The revised version was submitted on 2.21 and is currently under review since 2.23. Is there still hope for this submission???
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 14:06:04 評論於
How is the progress of your revision going??? Our major revision is given 60 days. Two reviewers did not require additional experiments, mainly focusing on clarifying some statements and adding details to the data analysis methods. All revisions have been explained and made, resubmitted on 2.21, and under review again on 2.23. As of now, there is still no news. Is there still hope for this???
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 11:34:35 評論於
Major revision, given 60 days. Two reviewers, no need for additional experiments, mainly issues with presentation and some clarification on data analysis methods, all addressed. Revised on 2.21, under review again on 2.23, still no news as of now. Is there still hope???
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 10:58:47 評論於
Major revision was given 60 days. Two reviewers did not request additional experiments, mostly addressing minor issues in wording and adding clarity to some data methods. All revisions were completed on 2.21, and the manuscript has been under review again since 2.23, now for over a month. Is there still hope for acceptance???
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 09:03:43 評論於
Major revision, given 60 days. Two reviewers, did not require additional experiments, mostly clarification of statements and supplementing data methods. Revised on 2/21, under review again on 2/23, still no news. Is there still hope???
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 08:46:37 評論於
Major revision, given 60 days. Two reviewers, no need for additional experiments, mostly just clarifications on wording and some supplementary data and methods, all addressed. Revised on 2.21, then back under review on 2.23, and still no updates until now. Is there still hope???
(0) 讚! | 岱宗雨旋

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 20:29:48 評論於
Does OA or non-OA affect online time? I chose non-OA
(0) 讚! | 墟散云泽

作者: 一条小秋华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 21:40:29 評論於
Just wait for them to notify, you can choose between OA and non-OA
(0) 讚! | 一条小秋华

作者: 一条小秋华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 17:21:38 評論於
Just waiting for the proof, it will be online very soon
(0) 讚! | 一条小秋华

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 23:13:39 評論於
After receiving it, should we wait for him to send another email to fill in some materials? The issue of layout fee was not mentioned, so I'm a bit confused, not sure what to do next
(0) 讚! | 墟散云泽

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 22:49:44 評論於
After receiving it, do I wait for him to send another email to fill in some materials? There was no mention of the layout fee, I am a bit confused, not sure what to do next
(0) 讚! | 墟散云泽

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 20:32:10 評論於
Do I need to provide all authors' consent forms after receiving the acceptance? And wait for the proof notification?
(0) 讚! | 墟散云泽

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-09 23:44:29 評論於
Reviewer for one month and then evaluating the recommendation, is there any hope for this situation?
(0) 讚! | 岱宗雨旋

作者: 岱宗雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-09 23:25:45 評論於
Review under one month and then evaluating recommendation, is there hope for this situation?
(0) 讚! | 岱宗雨旋

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)

開始撰寫 [MOLECULAR CARCINOGENESIS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*